According to Omnicell 's latest financial reports the company's current EPS (TTM) is HK$3.61. In 2024 the company made an earnings per share (EPS) of HK$2.12 an increase over its 2023 EPS that were of -HK$3.53.
Year | EPS | Change |
---|---|---|
2025 (TTM) | HK$3.57 | 68.66% |
2024 | HK$2.12 | -160% |
2023 | -HK$3.53 | -421.43% |
2022 | HK$1.10 | -92.18% |
2021 | HK$14.05 | 132.47% |
2020 | HK$6.04 | -47.97% |
2019 | HK$11.62 | 54.17% |
2018 | HK$7.54 | 74.55% |
2017 | HK$4.32 | 3747.5% |
2016 | HK$0.11 | -98.34% |
2015 | HK$6.75 | -0% |
2014 | HK$6.75 | 26.47% |
2013 | HK$5.34 | 38.78% |
2012 | HK$3.85 | 53.13% |
2011 | HK$2.51 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Cerner CERN | HK$15.70 | 334.78% | ๐บ๐ธ USA |
![]() Steris STE | HK$37.13 | 928.26% | ๐ฎ๐ช Ireland |
![]() AmerisourceBergen
ABC | HK$65.07 | 1,702.17% | ๐บ๐ธ USA |
![]() McKesson MCK | HK$172.37 | 4,673.91% | ๐บ๐ธ USA |
![]() Premier PINC | -HK$2.75 | -176.09% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | HK$50.47 | 1,297.83% | ๐บ๐ธ USA |